BridgeBio Pharma (BBIO) has no currently recruiting or active clinical trials where it is listed as lead sponsor on ClinicalTrials.gov.
BBIO has 5 Form 4 insider filings recorded at the SEC in the past 30 days[1].
Sources
- SEC EDGAR · 0001743881 (2026-04-11) ↗